The combined company's board will include six directors appointed by Nakamoto and one by KindlyMD, with all appointments to be announced before the deal closes. KindlyMD shares will remain listed on Nasdaq under the ticker "KDLY" until the merger is complete, after which the combined company plans to adopt a new name and trading symbol.